Metabolic Syndrome in HIV/HCV Co-infected Patients-Reference-Cited by-同舟云学术

Metabolic Syndrome in HIV/HCV Co-infected Patients

Published:2019-12 Issue:4 Volume:11 Page:351-371
ISSN:1534-6250
Container-title:Current Treatment Options in Infectious Diseases
language:en
Short-container-title:Curr Treat Options Infect Dis

Author:

Collins Lauren F.,Adekunle Ruth O.,Cartwright Emily J.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40506-019-00207-3.pdf

Reference125 articles.

1. Marcus JL, Chao CR, Leyden WA, et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr. 2016;73(1):39–46. https://doi.org/10.1097/QAI.0000000000001014.

2. Centers for Disease Control and Prevention. HIV surveillance report, 2017; vol. 29. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2018. Accessed [June 1, 2019].

3. Gallant J, Hsue PY, Shreay S, Meyer N. Comorbidities among US patients with prevalent HIV infection–a trend analysis. J Infect Dis. 2017;216(12):1525–33. https://doi.org/10.1093/infdis/jix518.

4. Neuhaus J, Angus B, Kowalska JD, et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24(5):697–706. https://doi.org/10.1097/QAD.0b013e3283365356.

5. Antiretroviral therapy cohort collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50(10):1387–96. https://doi.org/10.1086/652283.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis;Annals of Medicine;2023-01-19

2. Increased All-cause Mortality in People With HIV and Comorbidities: Hepatitis B and C Virus Seropositivity and Hyperglycemia in Myanmar, 2005–2017;Open Forum Infectious Diseases;2022-12-13

3. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27

4. Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients;BIOCELL;2022

5. Burden of Chronic Conditions Among Persons with HIV/AIDS and Psychiatric Comorbidity;Current HIV Research;2021-12-22